Discovery of (+)-N-(3-Aminopropyl)-N-[1-(5-benzyl-3-metlyl-4-oxo-[1,2]thiazolo[5,4-d]pyrimidin-6-yl)-2-metlylpropyl]-4-methylbenzamide (AZD4877), a Kinesin Spindle Protein Inhibitor and Potential Anticancer Agent

被引：40

作者：

Theoclitou, Maria-Elena ^{[1
]}

Aquila, Brian ^{[2
]}

Block, Michael H. ^{[2
]}

Brassil, Patrick J. ^{[2
]}

Castriotta, Lillian ^{[2
]}

Code, Erin ^{[2
]}

Collins, Michael P. ^{[2
]}

Davies, Audrey M. ^{[2
]}

Deegan, Tracy ^{[2
]}

Ezhuthachan, Jayachandran ^{[2
,3
]}

Filla, Sandra ^{[2
,3
]}

Freed, Ellen ^{[2
,3
]}

Hu, Haiqing ^{[2
]}

Huszar, Dennis ^{[2
]}

Jayaraman, Muthusamy

Lawson, Deborah ^{[2
]}

Lewis, Paula M. ^{[2
]}

Nadella, Murali V. P. ^{[2
]}

Oza, Vibha ^{[2
]}

Padmanilayam, Maniyan ^{[4
]}

Pontz, Timothy ^{[2
]}

Ronco, Lucienne ^{[2
,3
]}

Russell, Daniel ^{[2
]}

Whitston, David ^{[2
]}

Zheng, Xiaolan ^{[2
]}

机构：

[1] AstraZeneca, Canc & Infect Res Area, Macclesfield SK10 4TG, Cheshire, England

[2] AstraZeneca R&D Boston, Canc & Infect Res Area, Waltham, MA 02451 USA

[3] AstraZeneca Boston, Boston, MA USA

[4] Organix Inc, Woburn, MA 01801 USA

来源：

JOURNAL OF MEDICINAL CHEMISTRY | 2011年 / 54卷 / 19期

关键词：

MITOTIC MOTOR PROTEIN; ANTIMITOTIC DRUG; EG5; MICROTUBULES; MECHANISMS; RESISTANCE; CANCER; TAXOL; KSP; BIPOLARITY;

D O I：

10.1021/jm200629m

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

Structure activity relationship analysis identified (+)-N-(3-aminopropyl)-N-[1-(5-benzyl-3-methyl-4-oxo-[1,2]thiazolo[5,4-d]pyrimidin-6-yl)-2-methylpropyl]-4-methylbenzamide (AZD4877), from a series of novel kinesin spindle protein (KSP) inhibitors, as exhibiting both excellent biochemical potency and pharmaceutical properties suitable for clinical development. The selected compound arrested cells in mitosis leading to the formation of the monopolar spindle phenotype characteristic of KSP inhibition and induction of cellular death. A favorable pharmacokinetic profile and notable in vivo efficacy supported the selection of this compound as a clinical candidate for the treatment of cancer.

引用

页码：6734 / 6750

页数：17

共 50 条

[1] Synthesis of N-(1-(6-acetamido-5-phenylpyrimidin-4-y1) piperidin-3-yl) amide derivatives as potential inhibitors for mitotic kinesin spindle protein
Muthuraja, P.
Himesh, M.
Prakash, S.
Venkatasubramanian, U.
Manisankar, P.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2018, 148 : 106 - 115
[2] Synthesis of N-{4-[(2-amino-4-oxo-5-methyl-4,7-dihydro-3-H-pyrrolo[2,3-d]pyrimidin-6-yl)thio]benzoyl}-L-glutamic acid as potential dual inhibitor DHFR and TS.
Gangjee, A
Lin, X
McGuire, JJ
Kisliuk, RL
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2003, 225 : U198 - U198
[3] Synthesis of N-{4-[(2,4-diamino-5-methyl-4,7-dihydro-3H-pyrrolo[2,3-d]pyrimidin-6-yl)thio]benzoyl}-L-glutamic acid and N-{4-[(2-amino-4-oxo-5-methyl-4,7-dihydro-3H-pyrrolo[2,3-d]pyrimidin-6-yl)thio]benzoyl}-L-glutamic acid as dual inhibitors of dihydrofolate reductase and thymidylate synthase and as potential antitumor agents
Gangjee, A
Lin, X
Kisliuk, RL
McGuire, JJ
JOURNAL OF MEDICINAL CHEMISTRY, 2005, 48 (23) : 7215 - 7222
[4] Discovery and SAR of N-(1-((substituted piperidin-4-yl)methyl)-3-methoxypiperidin-4-yl)-2-methoxybenzamide derivatives: 5-Hydroxytryptamine receptor 4 agonist as a potent prokinetic agent
Park, Jung Sang
Im, Weonbin
Choi, Sunghak
Park, Sook Jin
Jung, Jun Min
Baek, Ki Seon
Son, Han Pyo
Sharma, Satyasheel
Kim, In Su
Jung, Young Hoon
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2016, 109 : 75 - 88
[5] Synthesis and biological evaluation of N-(3-fluorobenzyl)-4-(1-(methyl-d3)-1H-indazol-5-yl)-5-(6-methylpyridin-2-yl)-1H-imidazol-2-amine as a novel, potent ALK5 receptor inhibitor
Kang, Byung-Nam
Kang, Hong-Jun
Kim, Sunjoo
Lee, Jungwoo
Lee, Jinwoo
Jeong, Hee-Jin
Jeon, Seeun
Shin, Youngdo
Yoon, Cheolhwan
Han, Cheolkyu
Seo, Jeongbeob
Yun, Jaesook
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2023, 85
[6] Discovery of N-(6-(5-fluoro-2-(piperidin-1-yl)phenyl) pyridazin-3-yl)-1-(tetrahydro-2H-pyran-4-yl)methanesulfonamide as a brain-permeable and metabolically stable kynurenine monooxygenase inhibitor
Tsuboi, Katsunori
Kimura, Hidenori
Nakatsuji, Yoshie
Kassai, Momoe
Deai, Yoko
Isobe, Yoshiaki
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2021, 44
[7] Discovery of N-(4-(3-isopropyl-2-methyl-2H-indazol-5-yl)pyrimidin-2-yl)-4-(4-methylpiperazin-1-yl)quinazolin-7-amine as a Novel, Potent, and Oral Cyclin-Dependent Kinase Inhibitor against Haematological Malignancies
Huang, Jianhang
Wang, Xinren
Dong, Ruinan
Liu, Xiaoyue
Li, Hongmei
Zhang, Tianyi
Xu, Junyu
Liu, Chenhe
Zhang, Yanmin
Hou, Shaohua
Tang, Weifang
Lu, Tao
Chen, Yadong
JOURNAL OF MEDICINAL CHEMISTRY, 2021, 64 (17) : 12548 - 12571
[8] Synthesis of N-(3-(4-[11C]methylpiperazin-1-yl)-1-(5-methylpyridin-2-yl)-1H-pyrazol-5-yl)pyrazolo[1,5-α]pyrimidine-3-carboxamide as a new potential PET agent for imaging of IRAK4 enzyme in neuroinflammation
Wang, Xiaohong
Xu, Wenzhi
Miao, Caihong
Dong, Fugui
Li, Wei
Wang, Min
Gao, Mingzhang
Zheng, Qi-Huang
Xu, Zhidong
APPLIED RADIATION AND ISOTOPES, 2018, 132 : 6 - 12
[9] Discovery of 1-(2,4-Dichlorophenyl)-4-ethyl-5-(5-(2-(4-(trifluoromethyl)phenyl)ethynyl)thiophen-2-yl)-N-(piperidin-1-yl)-1H-pyrazole-3-carboxamide as a Potential Peripheral Cannabinoid-1 Receptor Inverse Agonist
Hung, Ming-Shiu
Chang, Chun-Ping
Li, Ting-Chieh
Yeh, Teng-Kuang
Song, Jen-Shin
Lin, Yinchiu
Wu, Chien-Huang
Kuo, Po-Chu
Amancha, Prashanth K.
Wong, Ying-Chieh
Hsiao, Wen-Chi
Chao, Yu-Sheng
Shia, Kak-Shan
CHEMMEDCHEM, 2010, 5 (09) : 1439 - 1443
[10] Synthesis and Molecular Structure of N-{(1R,5S)-3-Methyl-8-Oxo-1,3,4,5,6,8-Hexahydro-2H-1,5-Methanopyrido[1,2-α] [1,5]Diazocin-9-yl}Acetamide
Suponitskii, K. Yu.
Koval'skaya, A. V.
Tsypysheva, I. P.
CHEMISTRY OF NATURAL COMPOUNDS, 2014, 50 (03) : 581 - 582

← 1 2 3 4 5 →